Compounds > 1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide
Page last updated: 2024-08-25

1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide and Skin Neoplasms

1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide has been researched along with Skin Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Berrebi, KG; Gerami, P; Harview, CL; Liu, V; Olivares, S; Sargen, MR; Stone, MS; Swick, BL; Vest, BE1

Other Studies

1 other study(ies) available for 1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide and Skin Neoplasms

ArticleYear
Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report.
    Journal of cutaneous pathology, 2022, Volume: 49, Issue:12

    Topics: Biomarkers, Tumor; Gene Fusion; Humans; Melanocytes; Skin Neoplasms; Transcription Factors; Tripartite Motif Proteins; Ubiquitin-Protein Ligases

2022